HBOT: A Versatile Medical Intervention
Hyperbaric Oxygen Therapy (HBOT) has emerged as a versatile medical intervention gaining recognition for treating various acute and chronic conditions. With 14 FDA-approved applications and over 30 conditions approved by the European Committee for Hyperbaric Medicine, HBOT continues to expand its clinical reach.
How HBOT Works
The mechanism involves breathing pure oxygen in a pressurized room or chamber. Increased pressure enables lungs to gather more oxygen, which dissolves into the bloodstream at elevated concentrations, positively affecting the body's healing processes at the cellular level.
FDA-Approved Conditions
The U.S. Food and Drug Administration has approved HBOT for 14 conditions, including decompression sickness, carbon monoxide poisoning, and chronic non-healing wounds, highlighting the urgency and efficacy of HBOT in treating these conditions.
European Committee for Hyperbaric Medicine (ECHM) Approvals
The ECHM has granted approval for over 30 conditions, expanding the recognized applications of HBOT across neurological disorders and chronic inflammatory conditions as adjuvant treatment.
Ongoing Clinical Trials
Hundreds of completed and ongoing clinical trials continue to investigate HBOT's potential for traumatic brain injury, stroke rehabilitation, autoimmune diseases, and many other conditions.
Contact us to learn more: +1 (916) 912-3214